Skip to main content

Drugs & Therapy Perspectives

Ausgabe 12/2023

Inhalt (8 Artikel)

Open Access Adis Drug Q&A

Tezepelumab in severe asthma: a profile of its use

Yahiya Y. Syed

Open Access Original Research Article

The PHASTER Study: Economic and Organizational Impact of Subcutaneous (SC) Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Treatment of HER2+ Breast Cancer Patients

Elisabetta Munzone, Alessandra Fabi, Giuseppe Buono, Roberta Caputo, Emilia Montagna, Mara Negri, Francesco Nuzzo, Antonella Palazzo, Ida Paris, Luca Conti, Anna Baggi, Jean Marie Franzini, Michelino De Laurentiis

Acknowledgement to Referees

Acknowledgement to Referees